The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 29

Tuesday, January 15, 2013

Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 2916:15 EST Tuesday, January 15, 2013 CAMBRIDGE, Mass. (Business Wire) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2012 financial results on Tuesday, January 29, 2013 after the financial markets close. The company will host a conference call at 5:00 p.m. ET. The conference call will be webcast live and a link to the webcast may be accessed from the “Vertex Events” page of Vertex's website at A replay of the conference call and webcast will be archived on the company's website until February 5, 2013. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast. About Vertex Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis and other life-threatening diseases. Founded more than 20 years ago in Cambridge, Mass., we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and for three years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. Vertex's press releases are available at VRTX-WEB Vertex Pharmaceuticals IncorporatedKate Carlson, 617-341-6668Investor Relations